Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00830310 · ClinicalTrials.gov registry record · NA
Customized Medication Adherence Enhancement for Adults With Bipolar Disorder
A NA study of Bipolar Disorder, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT00830310: Completed NA study of Bipolar Disorder, sponsored by University Hospitals Cleveland Medical Center.
NCT00830310 is a NA study of Bipolar Disorder that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 43 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00830310, a NA study of Bipolar Disorder, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a modular intervention that is intended to improve treatment adherence among individuals with bipolar disorder on atypical antipsychotic therapy who have been identified as having treatment adherence problems.
Primary Outcome
Treatment non-adherence is measured as a percentage of medications not taken within the past month at time of assessment. The minimum score is 0 and the maximum score is 100. A higher score implies poorer treatment adherence.
Conditions Studied
Interventions
- BEHAVIORAL Psychoeducation module
- BEHAVIORAL Substance use module
- BEHAVIORAL Improved communication/rapport with provider module
- BEHAVIORAL Medication routines management module
Study Locations (1)
Ohio
- University Hospitals Case Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2009-01 |
| Est. Completion | 2010-10 |
| Phase | NA |
What the finished NCT00830310 record still lists
NCT00830310 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Bipolar Disorder appearing as the primary indexed condition, and to 4 interventions - of which Psychoeducation module is the first listed.
NCT00830310 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00830310 about?
NCT00830310 is a clinical study titled "Customized Medication Adherence Enhancement for Adults With Bipolar Disorder". This study is a modular intervention that is intended to improve treatment adherence among individuals with bipolar disorder on atypical antipsychotic therapy who have been identified as having treatment adherence problems.
What is the current status of trial NCT00830310?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2009-01. Estimated completion is 2010-10.
What conditions does trial NCT00830310 study?
This clinical trial studies the following conditions: Bipolar Disorder.
What interventions are being tested in trial NCT00830310?
The interventions under investigation include: Psychoeducation module (BEHAVIORAL), Substance use module (BEHAVIORAL), Improved communication/rapport with provider module (BEHAVIORAL), Medication routines management module (BEHAVIORAL).
Who is sponsoring clinical trial NCT00830310?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00830310 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00830310's enrollment target sits among peer trials
43 120th of 162 higher than 43 of 162 other Bipolar Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bipolar Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Intermittent Theta Burst Stimulation (iTBS) for Emotion Regulation in Bipolar Disorder
RECRUITING · NA
-
Healthy Lifestyles in Bipolar Disorder: Bay Area Study
RECRUITING · NA
-
A Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar Disorder
RECRUITING · NA
-
Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia